Titlebook: Balloon pulmonary angioplasty in patients with CTEPH; Francesco Saia,Nazzareno Galiè,Hiromi Matsubara Book 2022 Springer Nature Switzerlan

Engaging

Medical Treatment of Chronic Thromboembolic Pulmonary Hypertension,d drug therapy. Anticoagulation has been traditionally with oral vitamin K antagonists (VKA), but direct oral anticoagulants (DOACs) represent an attractive alternative, although some controversy exists. The rationale in support of PH-targeted medical therapy in CTEPH includes histopathological obse

拍下盜公款

Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: Modern Technique,ons for coronary or peripheral arteries. However, because of the unique features of pulmonary vasculature and disease, some differences between BPA and other interventions exist. Pulmonary vessel walls are fragile and vascular injury during procedures can easily cause life-threatening complications.

Alopecia-Areata

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Clinical Outcomes,thrombus plane in the proximal pulmonary artery and removal of a dissectate that represents the inside of the pulmonary arterial tree. However, a considerable proportion of patients are not eligible for surgery due to distal lesions or due to comorbidities resulting in an unfavorable risk/benefit ra

鐵砧

palpitate

Advanced Noninvasive Imaging to Guide Balloon Pulmonary Angioplasty,y hypertension (CTEPH) who are not candidates for pulmonary endarterectomy. However, we need to further improve the outcome, efficiency, and safety of BPA. In this context, it is important to sufficiently use noninvasive imaging such as computed tomography and cardiovascular magnetic resonance to gu

易發(fā)怒

Balloon Pulmonary Angioplasty in Proximal Lesions,patients cannot be candidates for PEA because of age or comorbidities, even though the lesions are surgically accessible and suitable for PEA. It is unclear whether balloon pulmonary angioplasty (BPA) can become an alternative treatment for such patients. In this chapter, we focus on the effectivene

允許

不安

inventory

Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: What Does the Futurreports were hampered by high adverse event rates, subsequent refinement and characterization of safe procedural technique have led to a significant decline in the all-comer adverse event rate, proving BPA to be a safe and effective therapy in selected patients with chronic thromboembolic pulmonary

motivate